Human Doctors or AI: Evaluating Patient Satisfaction in Urinary Stone Disease Consultations

NCT07111845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-08

No results posted yet for this study

Summary

The goal of this observational study is to understand how satisfied patients are after getting medical advice about urinary stone disease from either a real doctor or an artificial intelligence (AI) chatbot. We want to learn whether people feel more satisfied with the information and support they get from human doctors or from AI tools like ChatGPT, Gemini, Perplexity, or Copilot.

The main questions it aims to answer are:

* Are patients more satisfied after consulting a real doctor or an AI chatbot?
* Does the time spent in the consultation affect satisfaction?

Researchers will compare doctor consultations with consultations from different AI chatbots to see if there are differences in patient satisfaction.

Participants will:

* Ask all their medical questions about urinary stones to one of the sources (a doctor or a specific AI chatbot)
* Fill out a short questionnaire (CSQ-8) to rate how satisfied they felt with the answers they received

Conditions

  • Patient Satisfaction

Interventions

BEHAVIORAL

Medical Consultation

Participants will be randomly assigned to receive medical consultation about urinary stone disease from one of five sources: a real urologist (in-person) or one of four AI chatbots (ChatGPT, Gemini, Perplexity, or Microsoft Copilot). Each participant will be instructed to ask all their questions related to urinary stone disease and continue the consultation until they feel adequately informed. The consultation format (human vs. AI) will depend on group assignment. After the session, participants will complete a validated satisfaction questionnaire (CSQ-8) to assess their experience.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-05-20
Completion
2025-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111845 on ClinicalTrials.gov